한국어
English
Archive
Year
Class/Forum
Presentation Title
Speaker
GBC 2022
Keynote & Plenary
Plenary Session
Vaccines for Controlling Pandemic and Endemic Infectious Diseases -Lessons Learned and Lessons Forgotten
Myron Levine
Professor,
University of Maryland School
GBC 2022
Keynote & Plenary
Keynote Speech
Innovation Beyond Boundaries: how regulation enables change
Virginia Acha
Associate Vice President-Global Lead,
MSD
GBC 2022
Keynote & Plenary
Plenary Session
Global Partnership, the Key to Next Pandemic Response
Chang Won (Andrew) Chey
Executive Vice Chairman,
SK discovery
GBC 2022
Keynote & Plenary
Plenary Session
How can we ensure that R&D is linked to access for all?
Soumya Swaminathan
Chief Scientist,
WHO
GBC 2022
Keynote & Plenary
Plenary Session
Learnings and Innovations in Continuing to Address the COVID-19 Pandemic
John Perez
Senior Vice President,
AstraZeneca
GBC 2022
Keynote & Plenary
Plenary Session
Supporting Innovation: USP Biologics Program
Ronald Piervincenzi
CEO,
USP
GBC 2022
Vaccine
Vaccine Forum
Agile vaccine development and approval strategy towards early ending COVID-19 PHEIC due to incessantly emerging SARS-COV-2 virus variants
Jinho Shin
Medical Officer,
WHO WPRO
GBC 2022
Vaccine
Vaccine Forum
Lessons learnt and a look ahead for COVID-19 vaccines
Ralf Wagner
Head of section for viral vaccines,
Paul-Ehrlich-Institut
GBC 2022
Vaccine
Vaccine Forum
Regulation at speed
Marco Cavaleri
Head,
European Medicines Agency
GBC 2022
Vaccine
Vaccine Forum
SKYCovione Multi Inj. (GBP510) Development & Regulatory Strategy
SookMi Hwang
Team leader,
SK bioscience Co., Ltd.
GBC 2022
Recombinant Protein Products
Recombinant Protein Products Forum
Current and Future Biomarkers of Immuno-oncology for Immunologically-hot Tumors
Young Kwang Chae
Associate Professor,
Northwestern University Feinberg School of Medicine
GBC 2022
Recombinant Protein Products
Recombinant Protein Products Forum
Immune Checkpoint Blockade for Immunologically-cold Tumors
Hark Kyun Kim
Deputy Director,
National Cancer Center
GBC 2022
Recombinant Protein Products
Recombinant Protein Products Forum
Beyond PD1: New horizons in modulation of the tumor microenvironment
Drew Pardoll
Professor and Director of the Bloomberg-Kimmel Institute,
Johns Hopkins University
GBC 2022
Recombinant Protein Products
Recombinant Protein Products Forum
Quality Attributes for Monoclonal Antibody Checkpoint Inhibitors
Diane McCarthy
Senior Director, Science and Standards,
United States Pharmacopeia
GBC 2022
Recombinant Protein Products
Recombinant Protein Products Forum
Development of Pembrolizumab and Biomarker-Targeted Therapies for Gastric Cancer
Sukrut Shah
Senior Principal Scientist,
Merck Sharp & Dohme LLC
